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BACKGROUND
The age at which allergenic foods should be introduced into the diet of breast-fed 
infants is uncertain. We evaluated whether the early introduction of allergenic 
foods in the diet of breast-fed infants would protect against the development of 
food allergy.
METHODS
We recruited, from the general population, 1303 exclusively breast-fed infants who 
were 3 months of age and randomly assigned them to the early introduction of six 
allergenic foods (peanut, cooked egg, cow’s milk, sesame, whitefish, and wheat; 
early-introduction group) or to the current practice recommended in the United 
Kingdom of exclusive breast-feeding to approximately 6 months of age (standard-
introduction group). The primary outcome was food allergy to one or more of the 
six foods between 1 year and 3 years of age.
RESULTS
In the intention-to-treat analysis, food allergy to one or more of the six interven-
tion foods developed in 7.1% of the participants in the standard-introduction 
group (42 of 595 participants) and in 5.6% of those in the early-introduction group 
(32 of 567) (P = 0.32). In the per-protocol analysis, the prevalence of any food 
 allergy was significantly lower in the early-introduction group than in the standard-
introduction group (2.4% vs. 7.3%, P = 0.01), as was the prevalence of peanut 
allergy (0% vs. 2.5%, P = 0.003) and egg allergy (1.4% vs. 5.5%, P = 0.009); there 
were no significant effects with respect to milk, sesame, fish, or wheat. The con-
sumption of 2 g per week of peanut or egg-white protein was associated with a 
significantly lower prevalence of these respective allergies than was less consump-
tion. The early introduction of all six foods was not easily achieved but was safe.
CONCLUSIONS
The trial did not show the efficacy of early introduction of allergenic foods in an 
intention-to-treat analysis. Further analysis raised the question of whether the 
prevention of food allergy by means of early introduction of multiple allergenic 
foods was dose-dependent. (Funded by the Food Standards Agency and others; 
EAT Current Controlled Trials number, ISRCTN14254740.)
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The World Health Organization recommends exclusive breast-feeding of infants for their first 6 months of life.1 
Two national guidelines that had previously rec-
ommended the delayed introduction of aller-
genic foods have been withdrawn (see the Intro-
duction section in the Supplementary Appendix, 
available with the full text of this article at 
NEJM.org). In the 2010 United Kingdom Infant 
Feeding Survey, 45% of the mothers of infants 
8 to 10 months of age reported avoiding giving 
their infant a particular food: 48% avoided nuts, 
14% eggs, 10% dairy, and 6% fish.2 Fear of al-
lergy was the most common reason for avoiding 
foods, followed by a belief that the baby was too 
young.
Observational studies suggest that the early 
introduction of peanut,3 egg,4 or cow’s milk5 
may prevent the development of allergy to these 
foods. The randomized, controlled Learning 
Early about Peanut Allergy (LEAP) trial showed 
that the early consumption of peanut in high-
risk infants with severe eczema, egg allergy, or 
both reduced the development of peanut allergy 
by 80% by 5 years of age.6 The Persistence of 
Oral Tolerance to Peanut (LEAP-On) study has 
now shown that the absence of reactivity is 
maintained in these infants.7 However, the LEAP 
trial did not investigate the efficacy of introduc-
tion of other allergenic foods, nor did it examine 
whether this approach could prevent peanut 
allergy in children in the general population. 
The Enquiring about Tolerance (EAT) trial was 
therefore conceived to determine whether the 
early introduction of common dietary allergens 
(peanut, cooked hen’s egg, cow’s milk, sesame, 
whitefish, and wheat) from 3 months of age in 
exclusively breast-fed infants in the general 
population would prevent food allergies, as com-
pared with infants who were exclusively breast-
fed for approximately 6 months.
Me thods
Trial Design
This randomized, controlled trial was conducted 
at a single site in the United Kingdom. Ethics 
approval was provided by the St. Thomas’ Hos-
pital research ethics committee. Written informed 
consent was obtained from parents or guard-
ians, and safety data were reviewed by an inde-
pendent data and safety monitoring committee. 
The trial protocol is available at NEJM.org.
Trial Procedures
Enrollment took place from November 2, 2009, 
to July 30, 2012. Details of the trial procedures 
have been published previously.8 Singleton in-
fants who were 3 months of age and exclusively 
breast-fed were recruited from the general popu-
lation in England and Wales. Participants were 
randomly assigned by an independent online ser-
vice to the standard-introduction group or the 
early-introduction group (Fig. S1 in the Supple-
mentary Appendix). Participants in the standard-
introduction group were to be exclusively breast-fed 
to approximately 6 months of age. After 6 months 
of age, the consumption of allergenic foods was 
allowed according to parental discretion. After 
skin-prick testing in duplicate at baseline, par-
ticipants in the early-introduction group had six 
allergenic foods introduced: cow’s milk (yogurt) 
first, followed (in random order) by peanut, 
cooked (boiled) hen’s egg, sesame, and white-
fish; wheat was introduced last. The infants in 
the standard-introduction group did not under-
go skin-prick testing at baseline because the re-
sults could have influenced the timing of the 
introduction of allergenic foods.
Infants in the early-introduction group who 
had a wheal of any size on skin-prick testing at 
baseline underwent an open-label incremental 
food challenge totaling 2 g of protein of that 
food. Families of infants in the early-introduc-
tion group who had negative results on skin-
prick testing or who had positive results on 
skin-prick testing but negative results on the food 
challenge were asked to continue feeding their 
infants 2 g of the allergen protein twice weekly. 
Families of infants who had a positive result on 
the food challenge at baseline were instructed to 
avoid giving the infants that food but to con-
tinue feeding the infants the other foods.
All the families completed an online ques-
tionnaire each month to 1 year of age, and then 
every 3 months until the child reached 3 years of 
age. This questionnaire recorded the frequency 
of consumption of allergenic foods in the two 
groups. In addition, the parents of the partici-
pants in the early-introduction group kept a 
weekly diary to record the quantity of the six 
foods consumed.8
Peanut-protein levels were measured in dust 
collected from the participant’s bed at 3 months 
of age (before the consumption of allergenic 
foods commenced in the early-introduction 
group) and at 12 months of age as an indepen-
A Quick Take is 
available at 
NEJM.org 
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dent measure of adherence to the dietary inter-
vention.9,10 Participants had scheduled assess-
ments at 1 year of age and 3 years of age and had 
unscheduled clinic visits for the investigation of 
parent-reported symptoms that were suggestive 
of food allergy. Additional details are provided 
in the Methods section and Tables S1, S2, and S3 
and Figs. S2, S3, and S4 in the Supplementary 
Appendix.
Outcomes
The primary outcome was challenge-proven food 
allergy to one or more of the six early-introduc-
tion foods between 1 year and 3 years of age. In 
two exceptional circumstances, reactions to foods 
that occurred before 1 year of age were also 
included in the primary outcome. Categories of 
evidence for food allergy are presented in the 
Methods section in the Supplementary Appen-
dix. Secondary outcomes were allergy to indi-
vidual foods and positive results on skin-prick 
testing for individual foods.
Statistical Analysis
The statistical analysis followed a prespecified 
analysis plan. Post hoc analyses included a 
dominance analysis of factors contributing to 
having a positive result with respect to the pri-
mary outcome and to not adhering to the proto-
col in the two study groups. Dominance analysis 
discerns the relative importance of independent 
variables in an estimation model on the basis of 
the contribution of each variable to the fit statis-
tics of the overall model (all post hoc analyses 
are listed in the Methods section in the Supple-
mentary Appendix).
The intention-to-treat analysis for the pri-
mary outcome included all the participants who 
had data that could be evaluated. The analysis, 
which compared the proportion of participants 
in the two groups who had food allergy to one 
or more of the early-introduction foods, was 
performed with a chi-square test. For secondary 
analyses, comparisons were made with the chi-
square test or Fisher’s exact test, as appropriate. 
The trial had 80% power at the 5% significance 
level to detect a halving of the prevalence of food 
allergy, from 8% in the standard-introduction 
group to 4% in the early-introduction group.8
The per-protocol population included all par-
ticipants who adhered adequately to the as-
signed regimen, which was defined as follows. 
In each group, breast-feeding was continued to 
at least 5 months of age. In the standard-intro-
duction group, there was no consumption of pea-
nut, egg, sesame, fish, or wheat before 5 months 
of age and consumption of less than 300 ml per 
day of formula milk between 3 and 6 months of 
age. In the early-introduction group, there was 
consumption of at least five of the early-intro-
duction foods, for at least 5 weeks between 3 and 
6 months of age, of at least 75% of the recom-
mended dose (i.e., 3 g per week of allergenic 
protein). The per-protocol population for food-
specific allergy used the same consumption cri-
terion — consumption for at least 5 weeks be-
tween 3 and 6 months of age of at least 75% of 
the recommended dose of that food (i.e., 3 g per 
week of allergenic protein). The data set will be 
made publicly available by August 2017.
R esult s
Participant Population
The median age of the participants at enroll-
ment was 3.4 months. The two groups were 
balanced, except for a significantly higher rate 
of birth by cesarean section in the early-intro-
duction group than in the standard-introduction 
group (Table S4 in the Supplementary Appendix). 
A total of 91.3% of the participants attended the 
final clinic visit, 90.0% of whom attended with-
in the visit window (by 4 years of age). A total of 
94.0% of the participants’ families completed 
the 3-year questionnaire.
Food Allergy
A food allergy developed in 74 participants. In 
70 of these participants (39 in the standard-
introduction group and 31 in the early-introduc-
tion group), diagnoses were made on the basis 
of double-blind, placebo-controlled food chal-
lenges (primary-outcome categories 1A and 1B), 
and in 4 (3 in the standard-introduction group 
and 1 in early-introduction group), diagnoses 
were made on the basis of an allergic reaction 
that resulted in a wheal size of 5 mm or more in 
diameter on skin-prick testing (primary-outcome 
category 3). A diagnosis of any food allergy was 
significantly associated with the presence of 
eczema at enrollment, nonwhite race, and hav-
ing siblings. In the post hoc dominance analy-
sis, these three factors accounted for 92.6% of 
the variation in the fit statistic of the overall 
logistic model (Table S5 in the Supplementary 
Appendix).
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Food Consumption and Allergy  
in the Intention-to-Treat Analyses
For the primary outcome, 595 of 651 enrolled 
participants (91.4%) in the standard-introduc-
tion group and 567 of 652 (87.0%) in the early-
introduction group were included in the intention-
to-treat analysis (Fig. S1 in the Supplementary 
Appendix). The rate of the primary outcome was 
nonsignificantly lower in the early-introduction 
group than in the standard-introduction group 
(5.6% [32 of 567 participants] and 7.1% [42 of 
595], respectively), which represented a relative 
risk of 0.80 (95% confidence interval [CI], 0.51 to 
1.25; P = 0.32), with the point estimate represent-
ing a 20% lower prevalence in the early-introduc-
tion group (Fig. 1, and Table S6 in the Supple-
mentary Appendix). The prevalence of allergy to 
more than one food was nonsignificantly lower 
in the early-introduction group than in the 
standard-introduction group (P = 0.17) (Table S7 
in the Supplementary Appendix).
Peanut allergy occurred in 1.2% of the par-
ticipants in the early-introduction group and in 
2.5% of those in the standard-introduction group, 
representing a nonsignificant 51% lower relative 
risk in the early-introduction group (P = 0.11). 
Egg allergy occurred in 3.7% of the participants 
in the early-introduction group and in 5.4% of 
those in the standard-introduction group, repre-
senting a nonsignificant 31% lower relative risk 
in the early-introduction group (P = 0.17) (Fig. 1).
For other early-introduction foods, the preva-
lence of food allergy was 0.7% or less in each 
group (Fig. S5 in the Supplementary Appendix). 
Non–IgE-mediated allergy-type symptoms are 
discussed in Tables S8 and S9 and the Results 
section in the Supplementary Appendix.
Food Consumption and Allergy  
in the Per-Protocol Analysis
In the per-protocol analysis, the rate of the pri-
mary outcome was significantly lower in the 
early-introduction group than in the standard-
introduction group (2.4% [5 of 208 participants] 
vs. 7.3% [38 of 524]). The relative risk in the 
early-introduction group was 0.33 (95% CI, 0.13 
to 0.83; P = 0.01), representing a prevalence that 
was 67% lower than that in the standard-intro-
duction group (Fig. 1).
With regard to food-specific per-protocol 
consumption, the protective effects with respect 
to egg and peanut were larger in the early-intro-
duction group than in the standard-introduction 
group. In the per-protocol analysis of peanut 
consumption, there were no cases of peanut al-
lergy among the 310 participants in the early-
introduction group, as compared with 13 cases 
among 525 participants (2.5%) in the standard-
introduction group (P = 0.003) (Fig. 1). The prev-
alence of egg allergy among participants who 
adhered to the protocol with respect to egg 
consumption was 1.4% in the early-introduction 
group versus 5.5% in the standard-introduction 
group, representing a 75% lower relative risk 
(P = 0.009) (Fig. 1). The rates of food allergy in 
the per-protocol analysis were lower, but not 
significantly so, in the early-introduction group 
than in the standard-introduction group for 
milk (P = 0.63) and sesame (P = 0.56). There were 
no cases of wheat allergy in either group in the 
per-protocol analysis. The rate of fish allergy 
was nonsignificantly higher in the early-intro-
duction group than in the standard-introduction 
group (P = 1.00) (Fig. S5 in the Supplementary 
Appendix).
Figure 1 (facing page). Primary Outcome of Allergy  
to One or More Foods and Secondary Outcomes  
of Allergy to Peanut and to Egg.
The prevalence of IgE-mediated food allergy is shown 
with respect to one or more of the six early-interven-
tion foods (peanut, cooked egg, cow’s milk, sesame, 
whitefish, and wheat; Panel A), to peanut (Panel B), and 
to egg (Panel C). The results regarding IgE-mediated 
food allergy to the other early-introduction foods are 
shown in Figure S5 in the Supplementary Appendix. 
The first column shows the intention-to-treat analysis, 
the second column the per-protocol analysis, and the 
third column an adjusted per-protocol analysis. The 
 intention-to-treat analysis included all the participants 
who had data that could be evaluated; the per-protocol 
population included all participants who adhered ade-
quately to the assigned regimen. The adjusted per-pro-
tocol analysis was a conservative per-protocol analysis 
that adjusted the prevalence of food allergy in the stan-
dard-introduction group by subtracting the number of 
participants in the early-introduction group who had a 
positive result on the challenge at enrollment and who 
completed the trial with a confirmed food allergy from 
both the numerator (the number of participants with 
allergy in the standard-introduction group) and the de-
nominator (the number of participants in the standard-
introduction group who adhered to the protocol). P val-
ues are based on chi-square analyses or Fisher’s exact 
test, as appropriate. The relative risks with 95% confi-
dence intervals are shown in Table S6 (intention-to-
treat analysis) and Table S10A (per-protocol analysis) 
in the Supplementary Appendix.
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Although adjustment for multiple testing was 
not part of the statistical analysis plan, if these 
six component food tests were adjusted for mul-
tiple testing with the use of a Bonferroni correc-
tion, the critical value for statistical significance 
would be 0.0085 (i.e., 1 − 0.951/6). Under this 
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constraint, in the per-protocol analysis the effect 
on peanut allergy would remain significant, and 
the results for egg would remain borderline sig-
nificant (see the Discussion section in the Sup-
plementary Appendix).
Protective effects with respect to the primary 
outcome and with respect to peanut allergy and 
egg allergy remained significant in the conser-
vative adjusted per-protocol analysis. This analy-
sis was not adjusted for multiple comparisons 
(Fig. 1, and the Results section in the Supple-
mentary Appendix).
Participants in the two trial groups who did 
not adhere to the protocol or whose adherence 
could not be evaluated had rates of allergy that 
were similar to the rate among the participants 
in the standard-introduction group who adhered 
to the protocol. Statistical comparisons between 
the participants in the standard-introduction 
group who adhered to the protocol and the par-
ticipants in the early-introduction group who did 
not adhere to the protocol or whose adherence 
could not be evaluated were all nonsignificant 
(Table S10B in the Supplementary Appendix).
Results of Skin-Prick Testing
A similar pattern was seen for the results of 
skin-prick testing (Fig. 2). In the intention-to-treat 
analyses, the risk of a positive skin-prick test to 
any food was 22% lower in the early-introduc-
tion group than in the standard-introduction 
group at 12 months of age (P = 0.07) and 12% 
lower at 36 months of age (P = 0.47); both differ-
ences were nonsignificant. Positive skin-prick 
tests to wheat occurred significantly less fre-
quently in the early-introduction group than in 
the standard-introduction group at 12 months 
(1.3% vs. 3.2%, P = 0.03) and at 36 months of age 
(1.4% vs. 3.2%, P = 0.04). The prevalence of posi-
tive skin-prick tests at 12 months and 36 months 
of age was nonsignificantly lower in the early-
introduction group than in the standard-intro-
duction group for every other food, with the 
exception of fish at 12 months of age, which had 
a higher prevalence in the early-introduction 
group (Fig. 2, and Fig. S6 and Table S11 in the 
Supplementary Appendix).
In the per-protocol analyses, the early-intro-
duction group had a significant 42% lower rate 
of positive skin-prick tests to any food than the 
standard-introduction group at 12 months of age 
(P = 0.01) and a significant 67% lower rate at 36 
months of age (P = 0.002). On food-specific test-
ing, the relative risk of a positive result on skin-
prick testing at 12 months of age was consis-
tently lower, by approximately 50%, in the 
early-introduction group than in the standard-
introduction group for every food with the ex-
ception of fish; the difference was significant 
with respect to egg (P = 0.009) and peanut 
(P = 0.04). At 36 months of age, the effect was 
greater; the relative risk of a positive result on 
skin-prick testing was 67% lower in the early-
introduction group than in the standard-intro-
duction group with respect to peanut (P = 0.007), 
48% lower with respect to egg (P = 0.10), 88% 
lower with respect to milk (P = 0.02), 100% lower 
with respect to both sesame (P = 0.04) and fish 
(P = 0.17), and 69% lower with respect to wheat 
(P = 0.12). The rate of a positive skin-prick test to 
raw egg white was also lower in the early-intro-
duction group than in the standard-introduction 
group at 36 months of age; the 49% lower rela-
tive risk (P = 0.07) was similar to that observed 
with commercial egg extract (Fig. 2, and Table 
S11 in the Supplementary Appendix).
Adherence to the Protocol
A total of 92.9% of the participants in the stan-
dard-introduction group whose primary-outcome 
status could be determined (524 of 564 partici-
pants) adhered to the protocol (Fig. S1 in the 
Supplementary Appendix). In the dominance 
analysis, shorter duration of maternal education 
and maternal smoking accounted for the major-
ity of the variation in the fit statistic of the 
overall model (Tables S12 and S13 in the Supple-
mentary Appendix). A total of 85.6% of the par-
ticipants in the standard-introduction group con-
sumed no cow’s milk formula before 6 months 
of age.
A total of 42.8% of the participants in the 
early-introduction group whose primary-outcome 
status could be determined (208 of 486 partici-
pants) adhered to the protocol (representing 
31.9% of the total number of participants en-
rolled in the early-introduction group) (Fig. S1 in 
the Supplementary Appendix). Four factors ac-
counted for 78% of the nonadherence in the 
dominance analysis: nonwhite race (odds ratio, 
2.21; 95% CI, 1.18 to 4.14), parentally perceived 
symptoms in the child related to any of the early-
introduction foods (odds ratio, 1.70; 95% CI, 
1.02 to 2.86), reduced maternal quality of life 
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(psychological domain) (odds ratio, 0.69; 95% 
CI, 0.47 to 1.00), and the presence of eczema in 
the child at enrollment (odds ratio, 1.38; 95% CI, 
0.87 to 2.19) (Tables S12 and S14 in the Supple-
mentary Appendix).
The rate of adherence to the protocol with 
respect to individual foods in the early-introduc-
tion group varied. The rates were as follows: 
43.1% for egg (215 of 499 participants), 50.7% 
for sesame (266 of 505), 60.0% for fish (297 of 
495), 61.9% for peanut (310 of 501), and 85.2% 
for milk (415 of 487).
The levels of peanut protein in bed dust were 
similar at baseline in the early-introduction 
group and the standard-introduction group (me-
dian, 7.6 μg of peanut protein per gram of dust 
and 9.7 μg per gram, respectively). However, by 
1 year of age, the levels were significantly higher 
in the early-introduction group than in the 
standard-introduction group (387.9 μg of peanut 
protein per gram of dust vs. 77.0 μg per gram, 
P<0.001). At 1 year of age, participants in the 
early-introduction group who adhered to the 
protocol had higher levels of peanut protein in 
bed dust than did those in the same trial group 
who did not adhere to the protocol (P = 0.04) 
(Fig. S7 in the Supplementary Appendix). Fur-
ther details on adherence to the protocol are 
provided in the Results section in the Supple-
mentary Appendix.
 Dose–Response Analysis
Variations in the number of foods consumed, 
the weekly dose of each food consumed, and the 
number of weeks during which this dose was 
consumed resulted in a rate of adherence in the 
early-introduction group that ranged from 6% 
to 81%. The prevalence of food allergy overall 
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Figure 2. Secondary Outcome of Results on Skin-Prick 
Testing.
The prevalence of a positive skin-prick test (wheal of any 
size) is shown for one or more of the six early- interven-
tion foods (Panel A), peanut (Panel B), egg (Panel C), 
and raw egg white (Panel D; this test was performed 
only at the 36-month visit). Results of skin-prick test-
ing for the other early-introduction foods are shown in 
Figure S6 in the Supplementary Appendix. The first 
column shows the intention-to-treat analysis, and the 
second column the per-protocol analysis. P values are 
based on chi-square analyses. The group-specific denom-
inators and relative risks with 95% confidence intervals 
are shown in Table S11 in the Supplementary Appendix.
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and the prevalence of allergy to specific foods 
were reduced in concert with increases in any 
of these variables. At a consumption level of 
2 g or more per week of allergenic protein for 
4 or more weeks, peanut was consumed by 85.3% 
of the participants in the early-introduction group 
for whom adherence with peanut consumption 
could be determined (419 of 491 participants) 
and egg by 75.5% (370 of 490). The correspond-
ing rates of allergy were 0.2% for peanut and 
1.9% for egg. Details are provided in Tables S15A, 
S15B, and S16 in the Supplementary Appendix.
The mean weekly consumption of egg and 
peanut protein between enrollment and 6 months 
of age was calculated and divided into quartiles. 
The prevalence of allergy to peanut and egg and 
the prevalence of positive responses on skin-
prick testing to peanut, egg, and raw egg white 
diminished with increasing quartile levels of 
consumption (Fig. S8 in the Supplementary Ap-
pendix). The mean weekly consumption data 
were used to generate predictive probability plots 
that were based on logistic modeling; analysis 
showed that higher consumption was associated 
with a lower prevalence of allergy and sensitiza-
tion to that food (Fig. 3). The mean weekly con-
sumption of 2 g of peanut protein and 4 g of egg 
protein (equivalent to 2 g of egg-white protein) 
was associated with the prevention of these two 
respective food allergies. The consumption of 
cooked egg was equally effective in inhibiting 
reactivity to raw egg-white protein and egg ex-
tract on skin-prick testing at 3 years of age.
Safety
No deaths occurred in the trial. There were three 
life-threatening events, all of which occurred in 
the standard-introduction group; none were re-
lated to allergic disease (heart-valve damage, pro-
longed febrile convulsion, and extensive burns). 
There were no significant between-group differ-
ences in the rates of hospitalization. There were 
no cases of anaphylaxis with the introduction of 
foods at home in the early-introduction group. 
The use of the epinephrine autoinjector is dis-
cussed in the Results section in the Supplemen-
tary Appendix.
The rate of visits to the emergency depart-
ment was similar in the two groups. The early-
introduction regimen did not affect the growth 
of the participants or the duration of breast-
feeding.8 Details on safety outcomes are pro-
vided in Tables S17 through S28 and Figures S9 
through S19 in the Supplementary Appendix.
Results According to Skin-Prick Testing  
and Allergy Status at Baseline
At enrollment, 33 of the 652 participants in the 
early-introduction group (5.1%) had a positive 
skin-prick test to an early-introduction food. All 
33 participants were invited to undergo food 
challenges to the relevant foods: 7 participants 
had positive results (to one or more foods), 22 
had negative results (to one or more foods), 
and 4 did not return for the challenges. Of the 
7 participants who had a positive result on a 
challenge at baseline, 5 subsequently had a 
positive result with respect to the primary out-
come, 1 had a negative result, and 1 withdrew 
from the trial. Of the 22 participants who had 
negative results on the challenge at baseline, 
1 subsequently had a positive result with respect 
to the primary outcome, 3 could not be evalu-
ated, and 18 had a negative result. Details are 
provided in Table S29A in the Supplementary 
Appendix.
All the reactions in the seven participants 
who had positive results on challenges at base-
line were mild (Table S30 in the Supplementary 
Appendix). There were 10 positive challenges 
among these seven participants; 6 reactions re-
quired no treatment, and 4 were treated with 
antihistamines. There were no cases of anaphy-
laxis during the challenges, and no intramuscu-
lar epinephrine was administered.
Discussion
This trial did not show efficacy of early intro-
duction of allergenic foods versus standard in-
troduction in an intention-to-treat analysis; there 
was a nonsignificant 20% lower relative risk of 
food allergy in the early-introduction group than 
in the standard-introduction group. In the per-
protocol analysis, there was a significant 67% 
lower relative risk of food allergy overall in the 
early-introduction group. Unexpectedly, in the 
per-protocol analysis, significantly lower relative 
risks of peanut allergy and egg allergy were ob-
served in the early-introduction group than in 
the standard-introduction group (P = 0.003 and 
P = 0.009, respectively). The rates of other food 
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allergies were too low to show any effects. Never-
theless, at 36 months of age, the average relative 
risk of a positive skin-prick test to the six indi-
vidual foods was 79% lower in the early-intro-
duction group than in the standard-introduction 
group; findings were significant for peanut 
(P = 0.007), milk (P = 0.02), and sesame (P = 0.04). 
The efficacy of the intervention was related to 
the duration of consumption of the specific food 
and the quantity of food consumed between 
3 months and 6 months of age.
We found that the early introduction of aller-
genic foods was safe, with no cases of anaphy-
laxis during the initial introduction regimen and 
no adverse effects on breast-feeding or growth.8 
Partial adherence among participants in the 
early-introduction group was not associated with 
any increase in the prevalence of allergy. Seven 
participants in the early-introduction group had 
positive results on food challenges at baseline, 
and hence complete adherence to the early-intro-
duction protocol in this trial would not have pre-
vented all cases of food allergy from occurring.
The per-protocol consumption of cooked egg 
resulted in a lower rate of a positive skin-prick 
test to raw egg white (by 49%) and to commer-
cial egg extract, which suggests that the possible 
protective effect is not confined to the form in 
which the individual food is consumed. The Hen’s 
Egg Allergy Prevention (HEAP) study, which en-
rolled patients from the general population,11 and 
the Solids Timing for Allergy Research (STAR) 
study, which enrolled high-risk patients,12 intro-
duced raw-egg powder but showed significant 
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Figure 3. Dose–Response Analysis of the Relationship 
between Mean Weekly Dose of Peanut or Egg Protein 
Consumed and Allergy or Positive Result on Skin-Prick 
Testing to Peanut, Egg, and Raw Egg White.
Shown are the predictive probability plots that were 
generated from statistical models of the prevalence of 
peanut allergy and egg allergy (Panel A) and of a posi-
tive result on skin-prick testing to peanut and egg at  
12 months (Panel B) and to peanut, egg, and raw egg 
white at 36 months (Panel C), according to the mean 
weekly consumption of peanut and egg protein between 
enrollment and 6 months of age. The prevalence of both 
food allergy and positive skin-prick test diminishes with 
increasing levels of mean weekly consumption. Insets 
show the same data on an enlarged y axis. Plots of the 
raw data and the probability plots are shown in Figure 
S8 in the Supplementary Appendix.
The New England Journal of Medicine 
Downloaded from nejm.org at ST GEORGES University on May 20, 2016. For personal use only. No other uses without permission. 
 Copyright © 2016 Massachusetts Medical Society. All rights reserved. 
n engl j med 374;18 nejm.org May 5, 20161742
Th e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
side effects. Our data suggest that the introduc-
tion of cooked egg is a safe strategy and may be 
effective for prevention.
The rates of food allergy were higher among 
nonwhite participants than among whites and 
higher among participants with eczema at en-
rollment than among those without eczema — 
findings that are consistent with those in the 
literature; however, adherence to the trial proto-
col was significantly lower among participants in 
the early-introduction group who were nonwhite 
and was lower (but not significantly) among 
those who had eczema than among the rest of 
the standard-introduction group.13-15 Adherence 
was also lower in cases in which parents per-
ceived symptoms in their child with the early 
introduction of the foods and in cases in which 
mothers had a lower psychological quality of life 
at enrollment. These results raise the question of 
whether targeted clinical and dietetic support 
to these families at the earliest stages of food 
introduction could possibly augment adherence, 
and this concept requires further consideration 
if early introduction is to be considered as a 
policy to reduce the prevalence of food allergies.
The strengths of our trial included a high 
retention rate, the fact that nearly all cases of 
allergy were confirmed in a double-blind, placebo-
controlled challenge, the enrollment of an un-
selected population of exclusively breast-fed 
infants, and the fact that all the children with 
a positive skin-prick test were invited to undergo 
a food challenge. The main weakness of the study 
was the low rate of per-protocol adherence in the 
early-introduction group, as discussed below.
There are a number of possible explanations 
for the finding of efficacy at the per-protocol 
level as opposed to the intention-to-treat level. 
The first is that the early introduction of aller-
genic foods prevented the development of food 
allergy. This explanation has some plausibility, 
given the food-specific findings and an apparent 
dose–response relationship for protection against 
peanut allergy and egg allergy. Reverse causality 
would provide a second explanation, reflecting 
the possibility that infants with nascent food 
allergy were less likely to successfully consume 
the foods because of aversive feeding behavior, 
which is the first sign of clinical food allergy. If 
this were the case, we would anticipate an excess 
of food allergy among the participants in the 
early-introduction group who did not adhere to 
the protocol, but there was no evidence of this. 
Furthermore, the 3-month-old infants who were 
most at risk for nascent food allergy (positive 
skin-prick test at enrollment but negative result 
on the food challenge at baseline) did not have 
lower rates of adherence to the early-introduc-
tion protocol than those in this group who had 
a negative skin-prick test.
A third potential explanation is that of bias 
leading to a higher prevalence of atopy and food 
allergy among children outside the per-protocol 
analysis. This is an important consideration, 
given that only 31.9% of all the enrolled partici-
pants in the early-introduction group (208 of 652 
participants) adhered to the protocol and had a 
primary outcome that could be evaluated, as 
compared with 80.5% in the standard-introduc-
tion group (524 of 651). Differential attrition 
between the two groups potentially introduces 
bias. An analysis for evidence of bias in the par-
ticipants who were not in the group that adhered 
to the protocol does not provide an explanation 
for the apparent efficacy in the per-protocol 
analyses (Tables S12 and S31 in the Supplemen-
tary Appendix).
Finally, we eliminated the possibility that our 
findings were the result of an artifact of study 
design — the selective removal of participants 
who had food allergy at baseline exclusively 
from the early-introduction group. When the par-
ticipants were 3 months of age, we evaluated 
food allergy only in the early-introduction group. 
Participants with confirmed food allergy at this 
point were unable to adhere to the protocol, 
which thus artificially lowered the rate of food 
allergy in this group. We therefore undertook an 
adjusted per-protocol analysis in which we sub-
tracted the same number of participants with 
food allergy from the standard-introduction group. 
The results remained significant after the adjust-
ment (Fig. 1). Nevertheless, we cannot be certain 
whether unmeasured sources of bias still exist.
Modeling determined that 2 g or more of 
peanut or egg-white protein per week may pre-
vent these respective allergies. This level of con-
sumption matches the median level of consump-
tion observed in Israeli infants 8 to 14 months 
of age (7.1 g per month), who have a rate of 
peanut allergy that is 10 times lower than that 
among Jewish children in the United Kingdom, 
who consume very little peanut (0.17% vs. 1.85%).3 
In the EAT trial, this level of peanut consump-
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tion for at least 4 weeks also resulted in a rate of 
peanut allergy that was 10 times lower than that 
among the participants in the standard-intro-
duction group (2.5% vs. 0.2%) — a finding that 
mirrors that of Du Toit et al.3 The results of our 
trial are complementary to those of the LEAP 
trial. Only 9 of the 1303 participants in our trial 
would have been considered to be at sufficiently 
high risk to enroll in the LEAP trial. It should be 
noted that 76% of the participants in the stan-
dard-introduction group did not have eczema at 
3 months of age, and yet they accounted for 38% 
of the participants in the standard-introduction 
group with food allergy to one or more of the 
foods tested (Table S32 in the Supplementary Ap-
pendix; additional information regarding many 
of the findings discussed in this section is avail-
able in the Discussion section of the Supplemen-
tary Appendix).
This trial failed to show the efficacy of early 
introduction of allergenic foods as compared 
with standard introduction of those foods in an 
intention-to-treat analysis. Further analysis sug-
gests that the possibility of preventing food 
allergy by means of the early introduction of 
multiple allergenic foods in normal breast-fed 
infants may depend on adherence and dose.
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